Loading organizations...
§ Private Profile · Helsinki, Southern Finland, Finland
Metabolite extraction system for measuring NADs and glutathione.
NADMED has raised $3.9M across 1 funding round.
NADMED has raised $3.9M in total across 1 funding round.
NADMED has raised $3.9M across 1 funding round. Most recently, it raised $3.9M Series A in August 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Aug 22, 2024 | $3.9M Series A | Nordic Science Investments | — | Announced |
NADMED has raised $3.9M in total across 1 funding round.
NADMED's investors include Nordic Science Investments.